is doing DD
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nice.
Neccentric AI: use AI to source the leads in the business segments synergistic with our core. Neccentric Lending
Systems is a proprietary developed b2b platform which facilitates pre- approved transactions helping lenders
streamline-loan decision making improving the efficiency of the underwriting process.
Website looks amazing
For the time being I prefer they protect shareholder value by not filing
It's a nice opportunity for investors
jmho
$AXXA
bidding 0002 for a quick flip at 0003
I've seen tickers die of boredom cuz of lame retail manipulation...
100% higher is still very cheap imo,
you're not getting my cheap shares
very nice volume eod
Showing lovely signs of reversal here imo
MAXM from 0015 to 003, reversal soon imo
PAUL hasn't move from the 0.0524 <3 My gtc sell order is at 0.0523
Sounds very good to me!
Also I like that, in the youtube video I linked a few posts back, they have HUGE fields of baby plants.
Marijuana plants typically take 6 to 8 weeks to fully develop. The video was posted on Apr 8, 2019.
So if things work out normally I highly presume that this company, which is already beloved as you can see in the comments on instagram, will have beautiful news in the near future on top of the name change and all that.
I shall watch closely
nice. it's ungoogleable. interesting.
edit: the comments are also interesting imo.
last time the birdie sang was in April
https://twitter.com/globalcbd
https://www.instagram.com/globalcbdinc/
$NEMD interesting, I like is this part of the 8k:
Creditors are required to provide claims in writing under oath on or before June 1, 2019 or they will be barred under NRS §78.675
$NEMD Robert Stevens
In Case Number A-18-783145-C Nevada’s 8 th Judicial District appointed Robert Stevens as Receiver for INeedMD Holdings, Inc. on November 21, 2018. Creditors are required to provide claims in writing under oath on or before June 1, 2019 or they will be barred under NRS §78.675.
https://www.otcmarkets.com/filing/html?id=13078011&guid=AroyUH4SFOcZpih
$NEMD
Robert Stevens
https://www.otcmarkets.com/filing/html?id=13078011&guid=AroyUH4SFOcZpih
04/04/2019 Order Admitting to Practice
Comment
Order Admitting to Practice
ORDER ADMITTING TO PRACTICE
NAME, ESQ. having filed his/her Motion to Associate Counsel under Nevada Supreme Court Rule 42, together with a Verified Application for Association of Counsel, a Certificate of Good Standing for the state of , and the State Bar of Nevada Statement; said application having been noticed, no objections having been made, and the Court being fully apprised in the premises, and good cause appearing, it is hereby
ORDERED, that said application is hereby granted, and NAME, ESQ. is hereby admitted to practice in the above entitled Court for the purposes of the above entitled matter only.
Dated this day of , 20
DISTRICT JUDGE
Submitted by:
(insert NV counsel of Record
NV Bar #
Address
city, state, zip code)
In Case Number A-18-783145-C Nevada’s 8 th Judicial District appointed Robert Stevens as Receiver for INeedMD Holdings, Inc. on November 21, 2018. Creditors are required to provide claims in writing under oath on or before June 1, 2019 or they will be barred under NRS §78.675
https://www.otcmarkets.com/filing/html?id=13078011&guid=AroyUH4SFOcZpih
ofc not
I know. Not much volume coming in though.
1st resistance 15.34
15.60 might be full reversal?
CDEL has/had 10'000 shares on bid at 15.00
let's see what happens
May I ask what filing you are referring to?
I'm not so used to searching on sedar. So far it seems all "Non-issuer's submission to jurisdiction and appointment of agent" are selling shareholders where the name Stanley appears more than once.
Final short form prospectus - English Apr. 09
https://www.sedar.com/
Charlotte’s Web Holdings, Inc. (the “Company”, “Charlotte’s Web”, “us”, “we” or “our”) may offer, issue and sell, as
applicable, from time to time common shares (“Common Shares”), preferred shares (“Preferred Shares”), warrants
(“Warrants”) to acquire any of the other securities that are described in this short form base shelf prospectus (the
“Prospectus”), subscription receipts (“Subscription Receipts”) convertible into other Securities (as defined below),
units (“Units”) comprised of one or more of any of the other Securities that are described in this Prospectus, or any
combination of such Securities (all of the foregoing collectively, the “Securities” and individually, a “Security”), for up
to an aggregate offering price of C$500,000,000 (or its equivalent in any other currencies), in one or more
transactions during the 25-month period that this Prospectus, including any amendments hereto, remains effective.
The issued and outstanding Common Shares are listed on the Canadian Securities Exchange (the “CSE”) under the
symbol “CWEB”. On April 5, 2019, the last trading day prior to the date of this Prospectus, the closing price of the
Common Shares on the CSE was C$29.30. Unless otherwise specified in the applicable Prospectus
Supplement, each series or issue of Securities (other than Common Shares) will not be listed on any
securities exchange. Accordingly, there is currently no market through which the Securities (other than
Common Shares) may be sold and purchasers may not be able to resell any such Securities purchased
under this Prospectus and the Prospectus Supplement relating to such Securities. This may affect the
pricing of such Securities in the secondary market, the transparency and availability of trading prices, the
liquidity of such Securities and the extent of issuer regulation.
s. The Proportionate Voting Shares are convertible into Common Shares at a ratio of 400 Common Shares for
every one Proportionate Voting Share at any time at the option of the holders thereof and automatically in certain
other circumstances.
Our authorized share capital consists of an unlimited number of Common Shares of which 25,375,294 were issued and outstanding as of April 1, 2019
The Company received an exemption order dated August 23, 2018 from the securities regulatory authorities in each
of the Provinces of Canada (except Quebec) which provided an exemption from the provisions of National Instrument
41-101 - General Prospectus Requirements in relation to the qualification of the Common Shares as “restricted
securities”. Subject to compliance with certain disclosure requirements, the exemption order applied to the
Company’s IPO Prospectus, as well as applies to any other prospectuses that the Company may file under National
Instrument 44-102 - Shelf Distributions, including this Prospectus.
Issued and outstanding Proportionate Voting Shares, including fractions thereof, may at any time, subject to the FPI
Condition (as defined below), at the option of the holder, be converted into Common Shares at a ratio of 400
Common Shares per Proportionate Voting Share. Further, our Board may determine in the future that it is no longer
advisable to maintain the Proportionate Voting Shares as a separate class of shares (a “Conversion Event”) and
may cause all of the issued and outstanding Proportionate Voting Shares to be converted into Common Shares at a
ratio of 400 Common Shares per Proportionate Voting Share.
The Proportionate Voting Shares are not transferrable without approval of our Board, except to Permitted Holders (as
defined below) and in compliance with U.S. securities laws
The right to convert the Proportionate Voting Shares into Common Shares is subject to certain conditions in order to
maintain the Company’s status as a “foreign private issuer” under U.S. securities laws. Unless otherwise waived by
the Company, the right to convert the Proportionate Voting Shares is subject to the condition that the aggregate
number of Common Shares and Proportionate Voting Shares (calculated as a single class) held of record, directly or
indirectly, by residents of the United States (as determined in accordance with Rules 3b-4 and 12g3-2(a) under the
Exchange Act) may not exceed forty percent (40%) of the aggregate number of Common Shares and Proportionate
Voting Shares issued and outstanding after giving effect to such conversions (calculated as a single class) (the “FPI
Condition”). The FPI Condition may be waived at any time, and in connection with one or more conversion
instances, by the Board.
Since December 31, 2018, the date of the Company’s most recently filed financial statements, there have been no
material changes to the Company’s share and loan capitalization on a consolidated basis except the following:
(a) in January, 2019, the issuance of a total of 425,324 Common Shares on conversion of 1,063.31
Proportionate Voting Shares;
(b) in January, 2019, the issuance of a total of 1,555 Common Shares upon exercise of an outstanding broker
warrant;
(c) in February, 2019, the issuance of a total of 59,728 stock options to purchase Common Shares;
(d) in February, 2019, the issuance of a total of 74,003 Common Shares upon exercise of an outstanding broker
warrant;
(e) in February, 2019, the issuance of a total of 235,376 Common Shares on conversion of 588.44
Proportionate Voting Shares;
(f) in March, 2019, the issuance of a total of 2,652,060 Common Shares on conversion of 6,630.15
Proportionate Voting Shares;
(g) in March, 2019, the issuance of a total of 5,175 Common Shares upon exercise of an outstanding broker
warrant;
(h) in April, 2019 thus far, the issuance of a total of 956,000 Common Shares on conversion of 2,390.00
Proportionate Voting Shares;
(i) in April, 2019 thus far, the issuance of a total of 7,140 Common Shares upon exercise of an outstanding
broker warrant;
(j) in April, 2019 thus far, the issuance of a total of 504,922 Common Shares upon exercise of an outstanding
option; and
(k) in April, 2019, the issuance of a total of 40,565 stock options to purchase Common Shares and 8,530
Common Shares as restricted stock awards
From time to
time, share-based compensation may comprise a significant component of the Company’s compensation for key
personnel, and if the price of the Common Shares declines, it may be difficult to recruit and retain such individuals.
Subject to compliance with applicable securities laws and the terms of any applicable lock-up arrangements, the
Company’s officers, directors, the holders of Proportionate Voting Shares and their affiliates may sell some or all of
their Common Shares in the future. No prediction can be made as to the effect, if any, such future sales of Common
Shares will have on the market price of the Common Shares prevailing from time to time. However, the future sale of
a substantial number of Common Shares by our officers, directors, the holders of Proportionate Voting Shares and
their affiliates, or the perception that such sales could occur, could materially adversely affect prevailing market prices
for the Common Shares.
All of the Common Shares the Company may issue under this Prospectus (including Common Shares issuable upon
conversion or exercise of any Securities) and all currently outstanding Common Shares other than those subject to
lock-up agreements executed by certain existing shareholders will, subject to applicable securities laws, generally be
immediately available for resale in the public markets.
Additional Common Shares issuable upon the exercise of stock options or the conversion of Proportionate Voting
Shares may also become available for sale in the public market, which may also cause the market price of the
49
Common Shares to fall. Accordingly, if substantial amounts of Common Shares are sold in the public market, the
market price could fall.
The Common Shares have not been, and may never be, registered under the U.S. Securities Act.
The Common
Shares may bear a legend describing restrictions on transfer to U.S. persons and prohibiting hedging transactions in
the Common Shares unless in compliance with the U.S. Securities Act
Working Capital and Future Issuances
The Company may issue additional Common Shares in the future which may dilute a shareholder’s holdings in the
Company. The Articles permit the issuance of an unlimited number of Common Shares, an unlimited number of
Proportionate Voting Shares, and an unlimited number of Preferred Shares issuable in series, and Shareholders have
no pre-emptive rights in connection with any further issuances.
Dilution
The offering price of Common Shares or other Securities that are convertible or exchangeable into Common Shares
may significantly exceed the net tangible book value per share of the Common Shares. Accordingly, a purchaser of
Common Shares or other Securities that are convertible or exchangeable into Common Shares may incur immediate
and substantial dilution of his, her or its investment. If outstanding options and warrants to purchase Common Shares
are exercised or securities convertible into Common Shares are converted, additional dilution will occur. The
Company may sell additional Common Shares or other securities that are convertible or exchangeable into Common
Shares in subsequent offerings or may issue additional Common Shares or other securities to finance future
acquisitions.
The Company cannot predict the size or nature of future sales or issuances of securities or the effect, if any, that
such future sales and issuances will have on the market price of the Common Shares. Sales or issuances of
52
substantial numbers of Common Shares or other securities that are convertible or exchangeable into Common
Shares, or the perception that such sales or issuances could occur, may adversely affect prevailing market prices of
the Common Shares. With any additional sale or issuance of Common Shares or other securities that are convertible
or exchangeable into Common Shares, investors will suffer dilution to their voting power and economic interest in the
Company. Furthermore, to the extent holders of the Company’s stock options or other convertible securities convert
or exercise their securities and sell the Common Shares they receive, the trading price of the Common Shares on the
CSE may decrease due to the additional amount of Common Shares available in the market.
I hope you're right.
https://www.otcmarkets.com/stock/CWBHF/news/Charlottes-Web-Announces-Closing-of-Secondary-Offering-of-Common-Shares?id=228491
I was in the CAD one and am looking to maybe re-enter in the US.
Can I presume CSTI was the one diluting these past 5 days?
Savage dilution for such a pretty company.
Many OTC companies had many mysterious tiny dumps today.
It's not a NXEN thing.
So many green days yet the price keeps going down.
strange
RSI needs to cool off imo.
boring, I might re-enter at 0011
Vikram Grover
https://www.bloomberg.com/research/stocks/people/person.asp?personId=222673576&privcapId=121597
https://www.nseindia.com/live_market/dynaContent/live_watch/get_quote/GetQuote.jsp?symbol=TATAGLOBAL
https://www.xe.com/currencyconverter/convert/?Amount=215&From=INR&To=USD
215$ INR = 3.11$ USD
07/17/2019 Status Check
im starting to think this:
"03/13/2019 Petition for Appointment"
in_bi has been updated recently???
I know a Canadian lady who went to Vegas and she was not happy about the snow!
I guess it could explain this?
"03/13/2019 Petition for Appointment
Judicial Officer
Vacant, DC 9
Hearing Time
3:00 AM
Cancel Reason
Vacated - per Secretary"
in_bi
Or maybe my answer is there?
"02/27/2019 Notice and Order of Dismissal Pursuant to NRCP 41(a)(2)
Comment
Notice of Voluntary Dismissal"
A-19-788635-P
edit: oh yeah well, friday pm I am always a bit tired. Where is the "custodian plays for dummies" book?!
ehm... you lost me!
ranch media? itat? hi dad?
When I write INTR on otcm it proposes XON.
Apparently a certain Joel A. Liffman bought some shares?
https://www.marketwatch.com/investing/stock/xon/insiders?pid=136497636
5840???
I wish I had enough knowledge/experience to fully understand what's going on with this:
A-15-728991-C
I hope you're talking about the discussion here and not the crayolas lol.
I have a little. Hoping for an eow sale.
Also took a little chance with Grace Jones:
Does the link in the address bar ends with 52?
The one ending with 44 seems interesting also.
TRDX 0009, valentine revival AH,
Perhaps an indicator of things to come?
https://www.nvsos.gov/SOSEntitySearch/corpActions.aspx?lx8nvq=8yY4e%252b695A75Q8sydCltEg%253d%253d&CorpName=SCIMEDENT+HEALTH%2c+CORP